Evidence map›Paper›PMID 25033196›Full record

ArticlePloS one2014

Insights into alpha-hemolysin (Hla) evolution and expression among Staphylococcus aureus clones with hospital and community origin.

Ana Tavares, Jesper B Nielsen, Kit Boye, Susanne Rohde, Ana C Paulo, Henrik Westh, Kristian Schønning, Hermínia de Lencastre, Maria Miragaia

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. α-hemolysin polymorphisms in methicillin-resistantbioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Prevalence of the Virulence Genes ofAntibiotics (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Toxins · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Ana TavaresLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica (ITQB), Oeiras, Portugal.
Jesper B NielsenDept. of Clinical Microbiology 445, Copenhagen University Hospital, Hvidovre, Denmark.
Kit BoyeDept. of Clinical Microbiology 445, Copenhagen University Hospital, Hvidovre, Denmark.
Susanne RohdeDept. of Clinical Microbiology 445, Copenhagen University Hospital, Hvidovre, Denmark.
Ana C PauloMolecular Microbiology of Human Pathogens, ITQB, Oeiras, Portugal.
Henrik WesthDept. of Clinical Microbiology 445, Copenhagen University Hospital, Hvidovre, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Kristian SchønningDept. of Clinical Microbiology 445, Copenhagen University Hospital, Hvidovre, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Hermínia de LencastreLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica (ITQB), Oeiras, Portugal; Laboratory of Microbiology and Infectious Diseases, The Rockefeller University, New York, New York, United States of America.
Maria MiragaiaLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica (ITQB), Oeiras, Portugal; Laboratory of Bacterial Evolution and Molecular Epidemiology, ITQB, Oeiras, Portugal.
Copenhagen University Hospital · DKUniversity of Copenhagen · DKInstituto de Biologia Experimental e Tecnológica · PTInstituto Português Da Qualidade · PTRockefeller University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlpha-hemolysin (Hla) is a major virulence factor in the pathogenesis of Staphylococcus aureus infection, being active against a wide range of host cells. Although hla is ubiquitous in S. aureus, its genetic diversity and variation in expression in different genetic backgrounds is not known. We evaluated nucleotide sequence variation and gene expression profiles of hla among representatives of hospital (HA) and community-associated (CA) S. aureus clones.

methods51 methicillin-resistant S. aureus and 22 methicillin-susceptible S. aureus were characterized by PFGE, spa typing, MLST and SCCmec typing. The internal regions of hla and the hla promoter were sequenced and gene expression was assessed by RT-PCR.

resultsAlpha-hemolysin encoding- and promoter sequences were diverse, with 12 and 23 different alleles, respectively. Based on phylogenetic analysis, we suggest that hla may have evolved together with the S. aureus genetic background, except for ST22, ST121, ST59 and ST93. Conversely, the promoter region showed lack of co-evolution with the genetic backgrounds. Four non-synonymous amino acid changes were identified close to important regions of hla activity. Amino acid changes in the RNAIII binding site were not associated to hla expression. Although expression rates of hla were in general strain-specific, we observed CA clones showed significantly higher hla expression (p = 0.003) when compared with HA clones.

conclusionWe propose that the hla gene has evolved together with the genetic background. Overall, CA genetic backgrounds showed higher levels of hla expression than HA, and a high strain-to-strain variation of gene expression was detected in closely related strains.

Indexed as

Bacterial ToxinsBase SequenceCommunity-Acquired InfectionsCross InfectionDNA, BacterialHemolysin ProteinsHumansMethicillin ResistanceMicrobial Sensitivity TestsMultilocus Sequence TypingPhylogenyPolymorphism, Single NucleotidePromoter Regions, GeneticSequence Analysis, DNAStaphylococcal InfectionsStaphylococcus aureusBacterial ToxinsDNA, BacterialHemolysin Proteinsstaphylococcal alpha-toxinVirulence Factors

Identifiers

PMID25033196
PMCPMC4102472
OpenAlexW2032905483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.